Making Cancer History®: Free seminar comes to Raleigh
The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History® seminar to Raleigh, N.C., for the first time, 11:30 a.m. to 1 p.m., Wednesday, June 8, at the McKimmon Conference and Training Center, 1101 Gorman St. Renowned experts from the nation’s No. 1 hospital for cancer care will share recent developments in cancer research, care and prevention.
The free seminar is open to the public and...
MorphoSys, MD Anderson join forces to develop novel oncology therapeutics
MorphoSys AG and The University of Texas MD Anderson Cancer Center today announced a long-term strategic alliance for the discovery and...
MD Anderson study uncovers early genetic changes in premalignant colorectal tissue
Researchers at The University of Texas MD Anderson Cancer Center have discovered mutations that may fuel early cancer growth in precancerous...
MD Anderson and Ionis Pharmaceuticals form strategic alliance to advance novel cancer therapeutics
Ionis Pharmaceuticals, Inc.,and The University of Texas MD Anderson Cancer Center today announced the formation of a strategic alliance to discover and develop novel cancer therapeutics. Combining advances made with Ionis’ antisense technology, which provides enhanced potency for effectively engaging targets in solid and liquid tumors, with MD Anderson’s expertise will allow Ionis and MD Anderson to develop novel therapeutic strategies...
MD Anderson receives $10.6 million from CPRIT for lung cancer research
The University of Texas MD Anderson Cancer Center will receive $10.6 million in funding from the Cancer Prevention and Research Institute...
Strike out cancer and celebrate survivorship at the ballpark
A double-header of cancer prevention and Chihuahuas baseball is in store for El Pasoans as experts from The University of Texas MD Anderson...
Study shows possible ‘key’ to improved therapy for adrenocortical carcinoma
A study comprised of 39 international institutions revealed significant new findings about adrenocortical carcinoma (ACC), a rare cancer with...
Can gender play a role in determining cancer treatment choices?
It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular...
MD Anderson applauds extension of FDA regulatory authority to all tobacco products
The University of Texas MD Anderson Cancer Center fully supports new rules issued by the Food and Drug Administration (FDA) today to extend...
Study points to therapeutic target for common and aggressive ovarian cancer
Small, non-coding molecules called microRNAs are known to play an important role in cancer development. Researchers now have shown their significance...
Research findings reveal potential to reverse cancer-related nerve pain
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by...